Gene_set,Term,Overlap,P-value,Adjusted P-value,Old P-value,Old Adjusted P-value,Odds Ratio,Combined Score,Genes
KEGG_2021_Human,Mucin type O-glycan biosynthesis,3/36,0.0162684138811796,0.983285168677095,0,0,6.061325115562403,24.963748417974152,GALNT3;C1GALT1;GALNT8
KEGG_2021_Human,Pancreatic secretion,5/102,0.0183254831520082,0.983285168677095,0,0,3.449034164878083,13.79428337559054,CHRM3;CPA1;PLA2G10;PLCB1;SLC26A3
KEGG_2021_Human,Other types of O-glycan biosynthesis,3/47,0.0328037487705539,0.983285168677095,0,0,4.543451463790447,15.52593903678626,GALNT3;C1GALT1;GALNT8
KEGG_2021_Human,Glycosaminoglycan biosynthesis,3/53,0.0444357264956643,0.983285168677095,0,0,3.9970169491525422,12.445557569518424,CSGALNACT1;CHSY3;HS6ST3
KEGG_2021_Human,Renin-angiotensin system,2/23,0.0455747204795115,0.983285168677095,0,0,6.332368082368083,19.5568988305819,ACE2;ENPEP
KEGG_2021_Human,Phospholipase D signaling pathway,5/148,0.0708702743292436,0.983285168677095,0,0,2.334065252153989,6.178047108001811,RALA;GRM7;SPHK1;PLCB1;PIK3R5
KEGG_2021_Human,Oxytocin signaling pathway,5/154,0.0808570884686318,0.983285168677095,0,0,2.2393888723457867,5.632224300298709,GUCY1A2;OXTR;PLCB1;PIK3R5;KCNJ3
KEGG_2021_Human,Cholinergic synapse,4/113,0.0887458902274793,0.983285168677095,0,0,2.4456094364351246,5.923212640477541,CHRM3;PLCB1;PIK3R5;KCNJ3
KEGG_2021_Human,Riboflavin metabolism,1/8,0.1131840058919903,0.983285168677095,0,0,9.473304473304474,20.63987130919014,ENPP1
KEGG_2021_Human,NOD-like receptor signaling pathway,5/181,0.1342781940984918,0.983285168677095,0,0,1.8932283586720449,3.801302573039113,IFI16;TRPV2;TAB3;ANTXR2;PLCB1
KEGG_2021_Human,Synthesis and degradation of ketone bodies,1/10,0.1394252695424448,0.983285168677095,0,0,7.367377478488589,14.515402516497678,HMGCS1
KEGG_2021_Human,Morphine addiction,3/91,0.1544348276216332,0.983285168677095,0,0,2.2666409861325114,4.234047054345031,GABRR1;PDE4C;KCNJ3
KEGG_2021_Human,Salivary secretion,3/93,0.1615851500208751,0.983285168677095,0,0,2.216045197740113,4.039236618666796,CHRM3;GUCY1A2;PLCB1
KEGG_2021_Human,Circadian entrainment,3/97,0.1761745302656445,0.983285168677095,0,0,2.121312657771367,3.6831930088620752,GUCY1A2;PLCB1;KCNJ3
KEGG_2021_Human,Retrograde endocannabinoid signaling,4/148,0.179890275470272,0.983285168677095,0,0,1.847883597883598,3.1698746666289126,GABRR1;PLCB1;NDUFC2-KCTD14;KCNJ3
KEGG_2021_Human,Non-alcoholic fatty liver disease,4/155,0.2009573170581897,0.983285168677095,0,0,1.7615894039735098,2.8267568910400462,IRS1;NDUFC2-KCTD14;ADIPOR2;MAP3K11
KEGG_2021_Human,Long-term depression,2/60,0.2249553638693446,0.983285168677095,0,0,2.2884436160298227,3.4140221129782224,GUCY1A2;PLCB1
KEGG_2021_Human,Nitrogen metabolism,1/17,0.2253224315788269,0.983285168677095,0,0,4.142676767676767,6.173511676066833,CA9
KEGG_2021_Human,Phenylalanine metabolism,1/17,0.2253224315788269,0.983285168677095,0,0,4.142676767676767,6.173511676066833,GLYAT
KEGG_2021_Human,Serotonergic synapse,3/113,0.2375969170364779,0.983285168677095,0,0,1.8112788906009245,2.603133192862469,KCND2;PLCB1;KCNJ3
KEGG_2021_Human,cGMP-PKG signaling pathway,4/167,0.2386224176132273,0.983285168677095,0,0,1.6309002128458745,2.336872585390965,GUCY1A2;IRS1;PLCB1;PIK3R5
KEGG_2021_Human,Glutamatergic synapse,3/114,0.2415602416832779,0.983285168677095,0,0,1.7948694457169034,2.5498568481482,GRM7;PLCB1;KCNJ3
KEGG_2021_Human,Tight junction,4/169,0.2450584161558457,0.983285168677095,0,0,1.610966810966811,2.2654360346441096,ACTR3C;NEDD4;MARVELD3;RUNX1
KEGG_2021_Human,GnRH secretion,2/64,0.247004720562313,0.983285168677095,0,0,2.1403661726242373,2.9929763949245847,PLCB1;KCNJ3
KEGG_2021_Human,Neuroactive ligand-receptor interaction,7/341,0.2474997605427021,0.983285168677095,0,0,1.3949009198098647,1.9477638517530096,CHRM3;UTS2R;OXTR;GABRR1;CALCR;NPW;GRM7
KEGG_2021_Human,Cortisol synthesis and secretion,2/65,0.2525314930406528,0.983285168677095,0,0,2.1062848562848564,2.8987098981740487,PLCB1;PBX1
KEGG_2021_Human,Acute myeloid leukemia,2/67,0.263592758037793,0.983285168677095,0,0,2.041268191268191,2.721724840830218,CCNA2;RUNX1
KEGG_2021_Human,AMPK signaling pathway,3/120,0.2655492183190973,0.983285168677095,0,0,1.702303346371143,2.2571777625834466,CCNA2;IRS1;ADIPOR2
KEGG_2021_Human,Pantothenate and CoA biosynthesis,1/21,0.2705123096236039,0.983285168677095,0,0,3.3134680134680137,4.332152915067912,ENPP1
KEGG_2021_Human,Adipocytokine signaling pathway,2/69,0.2746557591961003,0.983285168677095,0,0,1.98013311819282,2.5588007856049764,IRS1;ADIPOR2
KEGG_2021_Human,Renin secretion,2/69,0.2746557591961003,0.983285168677095,0,0,1.98013311819282,2.5588007856049764,GUCY1A2;PLCB1
KEGG_2021_Human,Terpenoid backbone biosynthesis,1/22,0.2813930846883027,0.983285168677095,0,0,3.155523488856822,4.001212333042656,HMGCS1
KEGG_2021_Human,Platelet activation,3/124,0.2816990268453413,0.983285168677095,0,0,1.6456926740439837,2.0849544764047803,GUCY1A2;PLCB1;PIK3R5
KEGG_2021_Human,Purine metabolism,3/129,0.3020016554898639,0.983285168677095,0,0,1.5799838579499597,1.891750664946859,GUCY1A2;PDE4C;ENPP1
KEGG_2021_Human,FoxO signaling pathway,3/131,0.3101452999138693,0.983285168677095,0,0,1.5551377118644067,1.820622085135412,IRS1;SGK3;SGK2
KEGG_2021_Human,Alzheimer disease,7/369,0.3122980108811813,0.983285168677095,0,0,1.2851474245789902,1.495651210740724,FZD1;SEM1;CHRM3;FRAT2;IRS1;PLCB1;NDUFC2-KCTD14
KEGG_2021_Human,alpha-Linolenic acid metabolism,1/25,0.313074417008322,0.983285168677095,0,0,2.760662177328844,3.2059966370416184,PLA2G10
KEGG_2021_Human,Gastric acid secretion,2/76,0.3132542848513435,0.983285168677095,0,0,1.7921840759678598,2.080259756174664,CHRM3;PLCB1
KEGG_2021_Human,Vascular smooth muscle contraction,3/133,0.3182958986141298,0.983285168677095,0,0,1.5310560625814864,1.7527129127995549,GUCY1A2;PLA2G10;PLCB1
KEGG_2021_Human,Transcriptional misregulation in cancer,4/192,0.3212069411966202,0.983285168677095,0,0,1.4122159502098712,1.6038108460691227,CCNA2;NFKBIZ;PBX1;RUNX1
KEGG_2021_Human,Collecting duct acid secretion,1/27,0.3334180060566446,0.983285168677095,0,0,2.548044548044548,2.798665885135178,ATP6V0A4
KEGG_2021_Human,Apelin signaling pathway,3/137,0.334602782166062,0.983285168677095,0,0,1.4850493296230711,1.6258486023328211,SPHK1;PLCB1;PIK3R5
KEGG_2021_Human,Butanoate metabolism,1/28,0.3433634878529772,0.983285168677095,0,0,2.4535478239181945,2.622758372825856,HMGCS1
KEGG_2021_Human,Ubiquitin mediated proteolysis,3/140,0.3468235715797743,0.983285168677095,0,0,1.4523073116417171,1.5379049504377948,HERC3;NEDD4;UBE2J1
KEGG_2021_Human,Linoleic acid metabolism,1/29,0.3531610720899979,0.983285168677095,0,0,2.365800865800866,2.462398954876971,PLA2G10
KEGG_2021_Human,Taste transduction,2/86,0.3675268899843625,0.983285168677095,0,0,1.578024453024453,1.5795374517931726,CHRM3;PLCB1
KEGG_2021_Human,Insulin secretion,2/86,0.3675268899843625,0.983285168677095,0,0,1.578024453024453,1.5795374517931726,CHRM3;PLCB1
KEGG_2021_Human,Gap junction,2/88,0.3781946206464887,0.983285168677095,0,0,1.541169076052797,1.4985501203264957,GUCY1A2;PLCB1
KEGG_2021_Human,Rheumatoid arthritis,2/93,0.4045234335906943,0.983285168677095,0,0,1.456118206118206,1.3178533928878198,ATP6V0A4;TNFSF13B
KEGG_2021_Human,Cushing syndrome,3/155,0.4073963880476945,0.983285168677095,0,0,1.3079839429081177,1.1745285637821088,FZD1;PLCB1;PBX1
KEGG_2021_Human,Nicotinate and nicotinamide metabolism,1/35,0.4089612453376476,0.983285168677095,0,0,1.9477124183006536,1.741517613510767,ENPP1
KEGG_2021_Human,Pathways of neurodegeneration,8/475,0.4130216509517467,0.983285168677095,0,0,1.1362327401609689,1.0047197813701414,FZD1;SEM1;CHRM3;FRAT2;VAPB;PLCB1;NDUFC2-KCTD14;UBE2J1
KEGG_2021_Human,Starch and sucrose metabolism,1/36,0.4177831443772276,0.983285168677095,0,0,1.891967291967292,1.6512953818928695,ENPP1
KEGG_2021_Human,Fc gamma R-mediated phagocytosis,2/97,0.4251989182992871,0.983285168677095,0,0,1.3945234708392602,1.1925939293461791,ACTR3C;SPHK1
KEGG_2021_Human,African trypanosomiasis,1/37,0.4264738018702426,0.983285168677095,0,0,1.8393191170968948,1.5674757338636651,PLCB1
KEGG_2021_Human,Aldosterone-regulated sodium reabsorption,1/37,0.4264738018702426,0.983285168677095,0,0,1.8393191170968948,1.5674757338636651,IRS1
KEGG_2021_Human,Inflammatory mediator regulation of TRP channels,2/98,0.4303097680423171,0.983285168677095,0,0,1.3799268018018018,1.1636231912442152,TRPV2;PLCB1
KEGG_2021_Human,Melanogenesis,2/101,0.4454960207461297,0.983285168677095,0,0,1.337906087906088,1.0817866639078322,FZD1;PLCB1
KEGG_2021_Human,Longevity regulating pathway,2/102,0.4505080070393698,0.983285168677095,0,0,1.3244594594594594,1.0560967267484476,IRS1;ADIPOR2
KEGG_2021_Human,Wnt signaling pathway,3/166,0.4507563082654309,0.983285168677095,0,0,1.219028803161069,0.9713567975394136,FZD1;FRAT2;PLCB1
KEGG_2021_Human,Nicotine addiction,1/40,0.4517776418085139,0.983285168677095,0,0,1.697574030907364,1.3488331867338013,GABRR1
KEGG_2021_Human,Protein digestion and absorption,2/103,0.4554943211163228,0.983285168677095,0,0,1.311279100883061,1.031153208094069,ACE2;CPA1
KEGG_2021_Human,Bladder cancer,1/41,0.4599625075525098,0.983285168677095,0,0,1.655050505050505,1.2853292661662918,DAPK2
KEGG_2021_Human,Homologous recombination,1/41,0.4599625075525098,0.983285168677095,0,0,1.655050505050505,1.2853292661662918,SEM1
KEGG_2021_Human,NF-kappa B signaling pathway,2/104,0.4604546138848607,0.983285168677095,0,0,1.298357180710122,1.0069292087352568,TAB3;TNFSF13B
KEGG_2021_Human,"Parathyroid hormone synthesis, secretion and action",2/106,0.4702958188241505,0.983285168677095,0,0,1.2732588357588357,0.96053803737836,PDE4C;PLCB1
KEGG_2021_Human,Fat digestion and absorption,1/43,0.4759686604244128,0.983285168677095,0,0,1.5760782427449094,1.170085635457067,PLA2G10
KEGG_2021_Human,Calcium signaling pathway,4/240,0.4813231523145533,0.983285168677095,0,0,1.1222183788769746,0.8205844831534396,CHRM3;OXTR;SPHK1;PLCB1
KEGG_2021_Human,Basal transcription factors,1/45,0.4915019509577925,0.983285168677095,0,0,1.5042852770125497,1.0684778417207843,CCNH
KEGG_2021_Human,Type II diabetes mellitus,1/46,0.4990956402285324,0.983285168677095,0,0,1.4707818930041152,1.0221309630193487,IRS1
KEGG_2021_Human,Proteasome,1/46,0.4990956402285324,0.983285168677095,0,0,1.4707818930041152,1.0221309630193487,SEM1
KEGG_2021_Human,Shigellosis,4/246,0.500501929296523,0.983285168677095,0,0,1.0940574576938211,0.7572451140806117,ACTR3C;TAB3;U2AF1;PLCB1
KEGG_2021_Human,Carbohydrate digestion and absorption,1/47,0.5065763030818043,0.983285168677095,0,0,1.4387351778656126,0.978455478570718,PLCB1
KEGG_2021_Human,Nucleotide excision repair,1/47,0.5065763030818043,0.983285168677095,0,0,1.4387351778656126,0.978455478570718,CCNH
KEGG_2021_Human,Salmonella infection,4/249,0.509976596911368,0.983285168677095,0,0,1.080494238511731,0.7275944936340404,ACTR3C;RALA;RAB9A;TAB3
KEGG_2021_Human,Axon guidance,3/182,0.511349745354131,0.983285168677095,0,0,1.1091563298930025,0.7439128027890122,SEMA3C;EFNA5;LRRC4C
KEGG_2021_Human,Amino sugar and nucleotide sugar metabolism,1/48,0.513945616373338,0.983285168677095,0,0,1.408052152733004,0.937252770806617,CHIT1
KEGG_2021_Human,"Valine, leucine and isoleucine degradation",1/48,0.513945616373338,0.983285168677095,0,0,1.408052152733004,0.937252770806617,HMGCS1
KEGG_2021_Human,Intestinal immune network for IgA production,1/48,0.513945616373338,0.983285168677095,0,0,1.408052152733004,0.937252770806617,TNFSF13B
KEGG_2021_Human,Sphingolipid metabolism,1/49,0.5212052320017395,0.983285168677095,0,0,1.3786475869809205,0.8983424779250743,SPHK1
KEGG_2021_Human,Ether lipid metabolism,1/49,0.5212052320017395,0.983285168677095,0,0,1.3786475869809205,0.8983424779250743,PLA2G10
KEGG_2021_Human,Vibrio cholerae infection,1/50,0.5283567775332543,0.983285168677095,0,0,1.3504432075860646,0.8615604955292901,ATP6V0A4
KEGG_2021_Human,Cholesterol metabolism,1/50,0.5283567775332543,0.983285168677095,0,0,1.3504432075860646,0.8615604955292901,VAPB
KEGG_2021_Human,Sphingolipid signaling pathway,2/119,0.5315448236028493,0.983285168677095,0,0,1.1310348810348811,0.7147775696200853,SPHK1;PLCB1
KEGG_2021_Human,"Growth hormone synthesis, secretion and action",2/119,0.5315448236028493,0.983285168677095,0,0,1.1310348810348811,0.7147775696200853,IRS1;PLCB1
KEGG_2021_Human,Thyroid hormone signaling pathway,2/121,0.5405318132931283,0.983285168677095,0,0,1.1119123325005678,0.6840504513045479,PLCB1;MED17
KEGG_2021_Human,Endocrine and other factor-regulated calcium reabsorption,1/53,0.5491789092492463,0.983285168677095,0,0,1.2723387723387722,0.7625520795841759,PLCB1
KEGG_2021_Human,Cell cycle,2/124,0.5537876535827454,0.983285168677095,0,0,1.0844040762073548,0.6408545738607858,CCNA2;CCNH
KEGG_2021_Human,Regulation of lipolysis in adipocytes,1/55,0.5625487506101776,0.983285168677095,0,0,1.2250904102755955,0.704766925107363,IRS1
KEGG_2021_Human,Pyrimidine metabolism,1/56,0.5690847298009992,0.983285168677095,0,0,1.2027548209366392,0.67802409914532,ENPP1
KEGG_2021_Human,Epstein-Barr virus infection,3/202,0.5818304394659297,0.983285168677095,0,0,0.996661272464015,0.5397680394013386,SEM1;CCNA2;NEDD4
KEGG_2021_Human,Diabetic cardiomyopathy,3/203,0.5851826789217336,0.983285168677095,0,0,0.9916271186440678,0.5313447576974566,IRS1;PLCB1;NDUFC2-KCTD14
KEGG_2021_Human,Dopaminergic synapse,2/132,0.5878030081197129,0.983285168677095,0,0,1.0172557172557173,0.5405324641383581,PLCB1;KCNJ3
KEGG_2021_Human,VEGF signaling pathway,1/59,0.5881144329486433,0.983285168677095,0,0,1.1403692093347266,0.6053464479930848,SPHK1
KEGG_2021_Human,Oxidative phosphorylation,2/133,0.5919176176139586,0.983285168677095,0,0,1.0094388281411182,0.5293374196658425,ATP6V0A4;NDUFC2-KCTD14
KEGG_2021_Human,Mineral absorption,1/60,0.5942696670143449,0.983285168677095,0,0,1.1209838497974092,0.5833847442546068,SLC26A3
KEGG_2021_Human,Arachidonic acid metabolism,1/61,0.600333220722784,0.983285168677095,0,0,1.1022446689113357,0.5624428391856042,PLA2G10
KEGG_2021_Human,Autophagy,2/137,0.6080700720171425,0.983285168677095,0,0,0.9793293293293294,0.4871822152677592,IRS1;DAPK2
KEGG_2021_Human,Estrogen signaling pathway,2/137,0.6080700720171425,0.983285168677095,0,0,0.9793293293293294,0.4871822152677592,PLCB1;KCNJ3
KEGG_2021_Human,Rap1 signaling pathway,3/210,0.6081656530642617,0.983285168677095,0,0,0.957749938590027,0.4762966857992537,RALA;PLCB1;EFNA5
KEGG_2021_Human,PI3K-Akt signaling pathway,5/354,0.6097522455935785,0.983285168677095,0,0,0.9462921853760624,0.4681331657453965,IRS1;SGK3;EFNA5;SGK2;PIK3R5
KEGG_2021_Human,Basal cell carcinoma,1/63,0.6121907111057227,0.983285168677095,0,0,1.0665797762571956,0.5233828824798593,FZD1
KEGG_2021_Human,Spinocerebellar ataxia,2/143,0.6313822828186396,0.983285168677095,0,0,0.9373682192831128,0.4310429296524556,SEM1;PLCB1
KEGG_2021_Human,Long-term potentiation,1/67,0.6348640795229793,0.983285168677095,0,0,1.001734516886032,0.4551324189451716,PLCB1
KEGG_2021_Human,Retinol metabolism,1/68,0.6403228721433722,0.983285168677095,0,0,0.9867330016583749,0.4398685432151775,ALDH1A1
KEGG_2021_Human,Breast cancer,2/147,0.6463161526230563,0.983285168677095,0,0,0.9113233923578752,0.3977621264834837,FZD1;FRAT2
KEGG_2021_Human,Cell adhesion molecules,2/148,0.6499741896296605,0.983285168677095,0,0,0.90503517215846,0.3899096287159722,ESAM;LRRC4C
KEGG_2021_Human,Epithelial cell signaling in Helicobacter pylori infection,1/70,0.6509976461193449,0.983285168677095,0,0,0.958034450788074,0.4112355719392006,ATP6V0A4
KEGG_2021_Human,Prolactin signaling pathway,1/70,0.6509976461193449,0.983285168677095,0,0,0.958034450788074,0.4112355719392006,SOCS6
KEGG_2021_Human,Gastric cancer,2/149,0.6536021975815487,0.983285168677095,0,0,0.8988325059753631,0.3822342515775988,FZD1;FRAT2
KEGG_2021_Human,Adrenergic signaling in cardiomyocytes,2/150,0.6572002560105092,0.983285168677095,0,0,0.8927136596055515,0.374731291315562,PLCB1;PIK3R5
KEGG_2021_Human,Spliceosome,2/150,0.6572002560105092,0.983285168677095,0,0,0.8927136596055515,0.374731291315562,U2AF1;SF3B1
KEGG_2021_Human,Inositol phosphate metabolism,1/73,0.6664206324529508,0.983285168677095,0,0,0.9179760568649458,0.3725461039425317,PLCB1
KEGG_2021_Human,mTOR signaling pathway,2/154,0.6712947312141829,0.983285168677095,0,0,0.8690433854907539,0.3463546312884485,FZD1;IRS1
KEGG_2021_Human,PPAR signaling pathway,1/74,0.6714091529116156,0.983285168677095,0,0,0.9053549190535491,0.3606721799997825,HMGCS1
KEGG_2021_Human,Ras signaling pathway,3/232,0.6747411721989615,0.983285168677095,0,0,0.8647620457405077,0.3402199679379641,RALA;PLA2G10;EFNA5
KEGG_2021_Human,Thyroid hormone synthesis,1/75,0.6763233186713147,0.983285168677095,0,0,0.8930748930748931,0.3492673329386693,PLCB1
KEGG_2021_Human,Pathways in cancer,7/531,0.6807462731521887,0.983285168677095,0,0,0.8803940085517169,0.3385692695597712,FZD1;CCNA2;RALA;FRAT2;DAPK2;PLCB1;RUNX1
KEGG_2021_Human,Chronic myeloid leukemia,1/76,0.6811642343194706,0.983285168677095,0,0,0.8811223344556678,0.3383085376204616,RUNX1
KEGG_2021_Human,Metabolism of xenobiotics by cytochrome P450,1/76,0.6811642343194706,0.983285168677095,0,0,0.8811223344556678,0.3383085376204616,SULT2A1
KEGG_2021_Human,Pancreatic cancer,1/76,0.6811642343194706,0.983285168677095,0,0,0.8811223344556678,0.3383085376204616,RALA
KEGG_2021_Human,Bacterial invasion of epithelial cells,1/77,0.6859329879468998,0.983285168677095,0,0,0.8694843168527379,0.3277741470452271,ACTR3C
KEGG_2021_Human,Synaptic vesicle cycle,1/78,0.6906306517747338,0.983285168677095,0,0,0.8581485854213127,0.3176437939287454,ATP6V0A4
KEGG_2021_Human,JAK-STAT signaling pathway,2/162,0.6980752677067465,0.983285168677095,0,0,0.8252533783783784,0.2966194590022775,IL20RB;SOCS6
KEGG_2021_Human,Hippo signaling pathway,2/163,0.701292980818721,0.983285168677095,0,0,0.8200856135638744,0.2909905947096085,FZD1;FAT4
KEGG_2021_Human,Hepatocellular carcinoma,2/168,0.7169574726724351,0.983285168677095,0,0,0.7951807228915663,0.2645874421535483,FZD1;FRAT2
KEGG_2021_Human,Parkinson disease,3/249,0.7202285042742339,0.983285168677095,0,0,0.8042992972302604,0.2639603726062706,SEM1;NDUFC2-KCTD14;UBE2J1
KEGG_2021_Human,Complement and coagulation cascades,1/85,0.7216105676560274,0.983285168677095,0,0,0.7863556196889531,0.2565639850666594,KLKB1
KEGG_2021_Human,ErbB signaling pathway,1/85,0.7216105676560274,0.983285168677095,0,0,0.7863556196889531,0.2565639850666594,NRG1
KEGG_2021_Human,Colorectal cancer,1/86,0.725776252888684,0.983285168677095,0,0,0.7770647653000594,0.2490597501951827,RALA
KEGG_2021_Human,GABAergic synapse,1/89,0.7379042229948014,0.983285168677095,0,0,0.7504591368227732,0.2280954820737916,GABRR1
KEGG_2021_Human,Bile secretion,1/90,0.7418268840277336,0.983285168677095,0,0,0.7419891801914273,0.2215871835239478,SULT2A1
KEGG_2021_Human,Hypertrophic cardiomyopathy,1/90,0.7418268840277336,0.983285168677095,0,0,0.7419891801914273,0.2215871835239478,MYBPC3
KEGG_2021_Human,Tuberculosis,2/180,0.7517544653973905,0.983285168677095,0,0,0.7411175220163985,0.2114745625723617,SPHK1;ATP6V0A4
KEGG_2021_Human,GnRH signaling pathway,1/93,0.7532472446048301,0.983285168677095,0,0,0.7176840872493047,0.2033642253601376,PLCB1
KEGG_2021_Human,IL-17 signaling pathway,1/94,0.7569410144008408,0.983285168677095,0,0,0.7099308497157959,0.1976944073654203,TAB3
KEGG_2021_Human,Dilated cardiomyopathy,1/96,0.7641640386849219,0.983285168677095,0,0,0.6949140528087897,0.1869129803097996,MYBPC3
KEGG_2021_Human,Phosphatidylinositol signaling system,1/97,0.767694920187987,0.983285168677095,0,0,0.6876402918069585,0.1817865570081573,PLCB1
KEGG_2021_Human,Aldosterone synthesis and secretion,1/98,0.771173112384269,0.983285168677095,0,0,0.6805165052587733,0.1768270426061061,PLCB1
KEGG_2021_Human,Glycerophospholipid metabolism,1/98,0.771173112384269,0.983285168677095,0,0,0.6805165052587733,0.1768270426061061,PLA2G10
KEGG_2021_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.7779745520877116,0.983285168677095,0,0,0.6667006768016869,0.1673828484593392,PLCB1
KEGG_2021_Human,Viral protein interaction with cytokine and cytokine receptor,1/100,0.7779745520877116,0.983285168677095,0,0,0.6667006768016869,0.1673828484593392,IL20RB
KEGG_2021_Human,Progesterone-mediated oocyte maturation,1/100,0.7779745520877116,0.983285168677095,0,0,0.6667006768016869,0.1673828484593392,CCNA2
KEGG_2021_Human,Chemokine signaling pathway,2/192,0.7828141697577519,0.983285168677095,0,0,0.6938833570412518,0.1699042387314509,PLCB1;PIK3R5
KEGG_2021_Human,Amoebiasis,1/102,0.784574488541081,0.983285168677095,0,0,0.6534320098676535,0.1585315974569967,PLCB1
KEGG_2021_Human,Chagas disease,1/102,0.784574488541081,0.983285168677095,0,0,0.6534320098676535,0.1585315974569967,PLCB1
KEGG_2021_Human,T cell receptor signaling pathway,1/104,0.7909788720643804,0.983285168677095,0,0,0.6406786309698931,0.1502289021882982,GRAP2
KEGG_2021_Human,Amyotrophic lateral sclerosis,4/364,0.7942174971316807,0.983285168677095,0,0,0.7309901738473167,0.1684186224568838,SEM1;VAPB;NRG1;NDUFC2-KCTD14
KEGG_2021_Human,Pathogenic Escherichia coli infection,2/197,0.7947193269272395,0.983285168677095,0,0,0.6759182259182259,0.1553032126724801,ACTR3C;TAB3
KEGG_2021_Human,Th17 cell differentiation,1/107,0.8002313722221179,0.983285168677095,0,0,0.6224509243377168,0.1387159134862103,RUNX1
KEGG_2021_Human,Glucagon signaling pathway,1/107,0.8002313722221179,0.983285168677095,0,0,0.6224509243377168,0.1387159134862103,PLCB1
KEGG_2021_Human,Insulin resistance,1/108,0.8032239111355913,0.983285168677095,0,0,0.6166021586582334,0.1351109506243377,IRS1
KEGG_2021_Human,TNF signaling pathway,1/112,0.8147538607090493,0.983285168677095,0,0,0.594260927594261,0.1217457743504013,TAB3
KEGG_2021_Human,Toxoplasmosis,1/112,0.8147538607090493,0.983285168677095,0,0,0.594260927594261,0.1217457743504013,PIK3R5
KEGG_2021_Human,Leukocyte transendothelial migration,1/114,0.8202637815954871,0.983285168677095,0,0,0.5836834420905217,0.1156447950603934,ESAM
KEGG_2021_Human,Neurotrophin signaling pathway,1/119,0.8333344299309209,0.983285168677095,0,0,0.5588084232152029,0.1018820863250921,IRS1
KEGG_2021_Human,cAMP signaling pathway,2/216,0.8348589751720412,0.983285168677095,0,0,0.6153068956807275,0.1110582555053769,OXTR;PDE4C
KEGG_2021_Human,Huntington disease,3/306,0.8372065612884928,0.983285168677095,0,0,0.6510823963752308,0.1156872183245454,SEM1;PLCB1;NDUFC2-KCTD14
KEGG_2021_Human,Regulation of actin cytoskeleton,2/218,0.8386451280937357,0.983285168677095,0,0,0.6095470470470471,0.1072605505119993,CHRM3;ACTR3C
KEGG_2021_Human,MicroRNAs in cancer,3/310,0.8435659636090749,0.983285168677095,0,0,0.6424667365980236,0.1092946280543114,IRS1;ZFPM2;EFNA5
KEGG_2021_Human,Osteoclast differentiation,1/127,0.8523052221424302,0.983285168677095,0,0,0.5231147453369676,0.0835992679058383,CALCR
KEGG_2021_Human,Lysosome,1/128,0.8545199118549733,0.983285168677095,0,0,0.5189692197566214,0.0815899920579256,ATP6V0A4
KEGG_2021_Human,Relaxin signaling pathway,1/129,0.856701501442977,0.983285168677095,0,0,0.514888468013468,0.0796355994478909,PLCB1
KEGG_2021_Human,Yersinia infection,1/137,0.8730202725139714,0.983285168677095,0,0,0.4844028520499108,0.0657802127444852,ACTR3C
KEGG_2021_Human,Insulin signaling pathway,1/137,0.8730202725139714,0.983285168677095,0,0,0.4844028520499108,0.0657802127444852,IRS1
KEGG_2021_Human,Human papillomavirus infection,3/331,0.8735382266218986,0.983285168677095,0,0,0.6006821000413394,0.0812142549020596,FZD1;CCNA2;ATP6V0A4
KEGG_2021_Human,Measles,1/139,0.8768018273655791,0.983285168677095,0,0,0.4773337237105353,0.0627571070049855,RAB9A
KEGG_2021_Human,Signaling pathways regulating pluripotency of stem cells,1/143,0.8840314996973092,0.983285168677095,0,0,0.4637928581590553,0.0571683060621044,FZD1
KEGG_2021_Human,Endocytosis,2/252,0.8920363513194487,0.983285168677095,0,0,0.5257297297297298,0.0600637776320491,ACTR3C;NEDD4
KEGG_2021_Human,Phagosome,1/152,0.8987893637516555,0.983285168677095,0,0,0.4359488929025353,0.0465186121786854,ATP6V0A4
KEGG_2021_Human,Cellular senescence,1/156,0.9047325141404916,0.983285168677095,0,0,0.4246117084826762,0.0425104017970571,CCNA2
KEGG_2021_Human,Hepatitis C,1/157,0.9061631299218113,0.983285168677095,0,0,0.4218682552015885,0.0415691825705584,EIF3E
KEGG_2021_Human,Hepatitis B,1/162,0.91300133444612,0.983285168677095,0,0,0.4086621912708869,0.0371955894904546,CCNA2
KEGG_2021_Human,Prion disease,2/273,0.9162955256240636,0.983285168677095,0,0,0.4844669392639872,0.0423503267364534,SEM1;NDUFC2-KCTD14
KEGG_2021_Human,Protein processing in endoplasmic reticulum,1/171,0.924082470149318,0.983285168677095,0,0,0.386848880966528,0.0305432502672762,UBE2J1
KEGG_2021_Human,MAPK signaling pathway,2/294,0.9353741938760474,0.983285168677095,0,0,0.4491392077008515,0.0300063717327667,EFNA5;MAP3K11
KEGG_2021_Human,Cytokine-cytokine receptor interaction,2/295,0.9361715308017206,0.983285168677095,0,0,0.447583248777788,0.0295210513541984,IL20RB;TNFSF13B
KEGG_2021_Human,RNA transport,1/186,0.9395125943602588,0.983285168677095,0,0,0.3552097552097552,0.0221629769435428,EIF3E
KEGG_2021_Human,Neutrophil extracellular trap formation,1/189,0.9422009627140356,0.983285168677095,0,0,0.3494877856579984,0.0208073462835046,PLCB1
KEGG_2021_Human,Kaposi sarcoma-associated herpesvirus infection,1/193,0.9456010928549058,0.983285168677095,0,0,0.3421366442199775,0.0191372341216808,PIK3R5
KEGG_2021_Human,Viral carcinogenesis,1/203,0.9532543741169132,0.983285168677095,0,0,0.325032503250325,0.0155604408203749,CCNA2
KEGG_2021_Human,Proteoglycans in cancer,1/205,0.9546510558052778,0.983285168677095,0,0,0.3218129002442728,0.0149351409939034,FZD1
KEGG_2021_Human,Lipid and atherosclerosis,1/215,0.9610346653850472,0.983285168677095,0,0,0.306617577645615,0.0121864538282933,PLCB1
KEGG_2021_Human,Human T-cell leukemia virus 1 infection,1/219,0.963329765778041,0.983285168677095,0,0,0.3009297871683192,0.0112425833428856,CCNA2
KEGG_2021_Human,Human cytomegalovirus infection,1/225,0.9665222137025528,0.983285168677095,0,0,0.2927789802789803,0.009969416162418,PLCB1
KEGG_2021_Human,Thermogenesis,1/232,0.9698982307401404,0.983285168677095,0,0,0.2838048595624353,0.0086742485518006,NDUFC2-KCTD14
KEGG_2021_Human,Coronavirus disease,1/232,0.9698982307401404,0.983285168677095,0,0,0.2838048595624353,0.0086742485518006,ACE2
KEGG_2021_Human,Chemical carcinogenesis,1/239,0.972934798480494,0.983285168677095,0,0,0.2753586282998048,0.0075553478280887,SULT2A1
KEGG_2021_Human,Olfactory transduction,1/440,0.998740768575614,0.9994819949175512,0,0,0.1477416534364142,0.00018615816541798347,OR2H2
KEGG_2021_Human,Herpes simplex virus 1 infection,1/498,0.9994819949175512,0.9994819949175512,0,0,0.1301072427832991,6.741367484606147e-05,ZNF300
